NIAID Announces High-Priority Influenza Research Areas

Notice Number: NOT-AI-05-013

Key Dates
Release Date: December 7, 2004

Issued by
National Institute of Allergy and Infectious Diseases (NIAID), (

Research aimed at developing tools to control epidemic influenza and the increasing threat of pandemic influenza is one of NIAID's highest priorities. Influenza is both a major public health threat and a NIAID Biodefense Category C priority pathogen ( NIAID is issuing this notice to the NIH Guide to highlight its interest in receiving grant applications focused on influenza research. Areas of high priority include, but are not limited to, the following:

Applications on influenza may be submitted under any of the following appropriate NIAID programs that are currently available.

Biodefense and Emerging Infections Disease Research Opportunities (PA-04-119)
Cooperative Research Partnerships for Biodefense (AI-05-019)
Biodefense SBIR Program (PAS-02-149)
SBIR Advanced Technology – NIAID (SBIR-AT-NIAID) (PA-04-127)
NIH Small Research Grant Program (R03) (PA-03-108)
Assays for Influenza Therapeutics: Project BioShield (NOT-AI-05-045)

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.